KAIROS PHARMA, LTD. Shareholders' Equity
KAIROS PHARMA, LTD. (KAPA) had Shareholders' Equity of $4.19 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-12
- 2026-06-30: Stockholders' Equity Attributable to Parent $4.19M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $5.31M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $6.34M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $7.66M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $4.19M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $5.31M 10-Q · filed 2026-08-12 |
| 2025-12-31 | $6.34M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $7.66M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $6.00M 10-Q · filed 2026-08-12 |
| 2025-03-31 | $7.13M 10-Q · filed 2026-08-12 |
| 2024-12-31 | $4.78M 10-Q · filed 2026-08-12 |
| 2024-09-30 | $3.33M 10-Q · filed 2025-11-14 |
| 2024-06-30 | -$2.65M 10-Q · filed 2025-11-14 |
| 2024-03-31 | -$2.40M 10-Q · filed 2025-08-12 |
| 2023-12-31 | -$2.08M 10-K · filed 2026-03-31 |
| 2023-09-30 | -$1.87M 10-Q · filed 2024-11-14 |
| 2023-06-30 | -$1.56M 10-Q · filed 2024-11-14 |
| 2022-12-31 | -$1.18M 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |